Author:
Wu Xiaojuan,Wang Hongbo,Lian Yifan,Chen Lubiao,Gu Lin,Wang Jialiang,Huang Yanlin,Deng Meihai,Gao Zhiliang,Huang Yuehua
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359 (2015).
2. Bruix, J., Reig, M. & Sherman, M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology 150, 835 (2016).
3. Calvisi, D. F. et al. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology 137, 1816 (2009).
4. Huang, Y., Tong, S., Tai, A. W., Hussain, M. & Lok, A. S. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21. Gastroenterology 141(1412), 1421 (2011).
5. Huang, Y., Tai, A. W., Tong, S. & Lok, A. S. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. J Hepatol 58, 1068 (2013).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献